Literature DB >> 29221222

Polymyxin B hemoperfusion in septic shock: nothing overmuch (Meden Agan)!

Stavroula Ilia1, Panagiotis Briassoulis1, George Briassoulis1.   

Abstract

Entities:  

Year:  2017        PMID： 29221222      PMCID： PMC5708468          DOI： 10.21037/jtd.2017.08.106

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  26 in total

1.  Potential Survival Benefit of Polymyxin B Hemoperfusion in Septic Shock Patients on Continuous Renal Replacement Therapy: A Propensity-Matched Analysis.

Authors:  Masao Iwagami; Hideo Yasunaga; Eisei Noiri; Hiromasa Horiguchi; Kiyohide Fushimi; Takehiro Matsubara; Naoki Yahagi; Masaomi Nangaku; Kent Doi
Journal:  Blood Purif       Date:  2016-02-27       Impact factor: 2.614

Review 2.  Polymyxin B Hemoperfusion for Sepsis and Septic Shock: A Systematic Review and Meta-Analysis.

Authors:  Takero Terayama; Kazuma Yamakawa; Yutaka Umemura; Morio Aihara; Satoshi Fujimi
Journal:  Surg Infect (Larchmt)       Date:  2017-01-16       Impact factor: 2.150

3.  High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial.

Authors:  Olivier Joannes-Boyau; Patrick M Honoré; Paul Perez; Sean M Bagshaw; Hubert Grand; Jean-Luc Canivet; Antoine Dewitte; Claire Flamens; Wilfried Pujol; Anne-Sophie Grandoulier; Catherine Fleureau; Rita Jacobs; Christophe Broux; Hervé Floch; Olivier Branchard; Stephane Franck; Hadrien Rozé; Vincent Collin; Willem Boer; Joachim Calderon; Bernard Gauche; Herbert D Spapen; Gérard Janvier; Alexandre Ouattara
Journal:  Intensive Care Med       Date:  2013-06-06       Impact factor: 17.440

4.  Polymyxin-B immobilized column-direct hemoperfusion for adolescent toxic shock syndrome.

Authors:  Etsuro Nanishi; Yuichirou Hirata; Sooyoung Lee; Noriyuki Kaku; Kenta Momii; Kensuke Kubota; Hisanori Nishio; Yoshihiko Maehara; Toshiro Hara
Journal:  Pediatr Int       Date:  2016-10       Impact factor: 1.524

5.  Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension.

Authors:  K Varga; J A Wagner; D T Bridgen; G Kunos
Journal:  FASEB J       Date:  1998-08       Impact factor: 5.191

6.  Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.

Authors:  Dinna N Cruz; Massimo Antonelli; Roberto Fumagalli; Francesca Foltran; Nicola Brienza; Abele Donati; Vincenzo Malcangi; Flavia Petrini; Giada Volta; Franco M Bobbio Pallavicini; Federica Rottoli; Francesco Giunta; Claudio Ronco
Journal:  JAMA       Date:  2009-06-17       Impact factor: 56.272

7.  Glutamine suppresses Hsp72 not Hsp90α and is not inducing Th1, Th2, or Th17 cytokine responses in human septic PBMCs.

Authors:  Efrossini Briassouli; Dimitris Goukos; George Daikos; Kleovoulos Apostolou; Christina Routsi; Serafim Nanas; George Briassoulis
Journal:  Nutrition       Date:  2014-02-22       Impact factor: 4.008

8.  Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort study.

Authors:  Yoshihiko Nakamura; Taisuke Kitamura; Fumiaki Kiyomi; Mineji Hayakawa; Kota Hoshino; Yasumasa Kawano; Reiko Yamasaki; Takeshi Nishida; Mariko Mizunuma; Hiroyasu Ishikura
Journal:  Crit Care       Date:  2017-06-07       Impact factor: 9.097

9.  Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors.

Authors:  Vincenzo Cantaluppi; Barbara Assenzio; Daniela Pasero; Giuseppe Mauriello Romanazzi; Alfonso Pacitti; Giacomo Lanfranco; Valeria Puntorieri; Erica L Martin; Luciana Mascia; Gianpaola Monti; Giampaolo Casella; Giuseppe Paolo Segoloni; Giovanni Camussi; V Marco Ranieri
Journal:  Intensive Care Med       Date:  2008-05-08       Impact factor: 17.440

Review 10.  Heat shock protein 72 expressing stress in sepsis: unbridgeable gap between animal and human studies--a hypothetical "comparative" study.

Authors:  George Briassoulis; Efrossini Briassouli; Diana-Michaela Fitrolaki; Ioanna Plati; Kleovoulos Apostolou; Theonymfi Tavladaki; Anna-Maria Spanaki
Journal:  Biomed Res Int       Date:  2014-01-12       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.